Tag: Humira
Adalimumab + Methotrexate Beneficial for Pediatric Crohn Disease
Reduction in treatment failure seen for adalimumab, but not infliximab, initiators treated with methotrexate combination therapy
Adalimumab Efficacious Adjunct to Surgery for Hidradenitis Suppurativa
Risk for postoperative wound infection, complications, hemorrhage no greater with adalimumab versus placebo in hidradenitis suppurativa
Risk for Birth Defects Not Increased With Adalimumab
Risk for preterm delivery higher in women with RA, Crohn disease regardless of adalimumab exposure
Longitudinal TNF Levels Mainly Stable With Adalimumab in RA
Early low TNF strongly associated with formation of antidrug antibodies, may predict nonresponse
California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira
Claims physicians prescribed Humira because of financial kickbacks, not as best drug for patient
ABP 501, Adalimumab Biosimilar, Safe and Effective, for Psoriasis
Findings based on comparison over 52 weeks, including single transition
Drug-Induced Lupus Seen With Adalimumab Treatment
Patient with psoriasis developed muscle pain with paresthesia, ANA titer elevation with adalimumab
Study Compares Effectiveness of Biologics in Psoriasis Treatment
Ustekinumab had highest effectiveness during five years of tx; more dose escalation for etanercept
Adalimumab Found to Be Effective for Noninfectious Uveitis
Reduces the worsening of inflammatory measures; significantly lowers risk of uveitic flare
Adalimumab Effective for Hidradenitis Suppurativa
Findings from two phase 3 trials show increased clinical response rates compared with placebo
